AWMDMG
VTAE

Austin W. Marxe & David M. Greenhouse’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6.29M Buy
+825,000
New +$6.41M 0.86% 40

Other funds holding VTAE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's VTAE Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse opened a new position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2014: 825,000 shares worth $6.29M. The stake represents 0.86% of the portfolio and ranks #40 among its holdings.

15 funds tracked by Wall St. Rank hold VTAE as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 825,000 shares of VITAE PHARMACEUTICALS INC COMMON STOCK worth $6.29M as of Q3 2014.
  • VITAE PHARMACEUTICALS INC COMMON STOCK was a new Austin W. Marxe & David M. Greenhouse position in Q3 2014.
  • VITAE PHARMACEUTICALS INC COMMON STOCK made up 0.86% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #40 holding.
  • 15 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.